AVENUE THERAPEUTICS INC
For the period ended Sep 30, 2024. Filed Nov 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 14, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
On* November 13, 2024,we agreed to issue122,850* shares of our common stock to Fortress in exchange for the conversion of*$250,000* of indebtedness owed under the Management Services Agreement with Fortress. The issuance was made pursuant to a privately negotiated transaction exempt from the registration requirements of the Securities Act of1933, as amended, pursuant to Section4(a)(2) thereof. See Note9, “Subsequent Events”, to our unaudited consolidated financial statements contained in Part I, Item1 of this Quarterly Report on Form10-Q.
During thethree months ended* September 30, 2024,none of our directors or officers (as defined in Rule16a*-1(f) of the Exchange Act) adopted, modified, or terminated a Rule10b5-1 trading arrangement or non-Rule10b5-1 trading arrangement (as such terms are defined in Item408 of Regulation S-K of the Securities Act).
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.